Pharmaceuticals

Vyndaqel Industry Forecast to Hit $3.58 Billion by 2029 With a Strong 17.3% CAGR

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Vyndaqel Market?

The vyndaqel market size has seen substantial growth recently and is anticipated to expand from $1.62 billion in 2024 to $1.9 billion in 2025, achieving a compound annual growth rate (CAGR) of 17.0%. The growth observed in previous periods is attributable to factors including heightened awareness of transthyretin amyloidosis, an increased occurrence of transthyretin-mediated amyloidosis cardiomyopathy, a greater focus on rare diseases, augmented government support, a rise in clinical trials, and an expanding geriatric demographic.

The market for vyndaqel is projected to experience swift expansion in the coming years. Its valuation is anticipated to reach $3.58 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.3%. Factors contributing to this expansion during the forecast period include enhanced investment in research and development activities, the rising acceptance of precision medicine, greater recognition among physicians, wider access to diagnostic instruments, and expanding governmental programs. Key trends anticipated in this timeframe encompass the proliferation of telemedicine, strategic partnerships, significant progress in genetic testing, the integration of digital health solutions, and the push towards personalized medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21321&type=smp

What Are The Key Drivers Of Growth In The Vyndaqel Market?

The future expansion of the vyndaqel market is expected to be driven by increasing investment in research and development. This involves the systematic investigation and experimentation aimed at innovating and improving products, services, or processes. The heightened investment in this area is a result of the rising prevalence of neurological disorders, ongoing advancements in medical technology, a growing awareness and demand for novel treatments, and substantial funding initiatives from both government and private sectors. Such investment accelerates the development and optimization of therapies, thereby enhancing their efficacy and accessibility for patients. Specifically for vyndaqel, it propels advancements, improving its effectiveness, accessibility, and potential for expanded indications. For instance, according to a July 2024 report from the UK’s Department of Health and Social Care, the business enterprise sector in the UK conducted pharmaceutical research and development worth approximately $11.1 billion in 2922, representing 0.36% of the nation’s gross domestic product. Consequently, the increasing investment in research and development is a key factor driving the growth of the vyndaqel market.

What Are The Major Segment Types Covered In The Vyndaqel Market?

The vyndaqel market covered in this report is segmented –

1) By Product Type: Vyndaqel (Tafamidis 20 mg), Vyndamax (Tafamidis 61 mg)

2) By Disease Type: Familial Amyloid Polyneuropathy (FAP), Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM)

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Vyndaqel (Tafamidis 20 mg): Oral Tablets, Oral Solution

2) By Vyndamax (Tafamidis 61 mg): Oral Capsules, Oral Suspension

Which Leading Companies Dominate The Vyndaqel Market Share?

Major companies operating in the vyndaqel market are Pfizer Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/vyndaqel-global-market-report

Which Geographies Are Emerging As Strong Markets For The Vyndaqel Industry?

North America was the largest region in the vyndaqel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vyndaqel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Vyndaqel Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21321&type=smp

Browse Through More Reports Similar to the Global Vyndaqel Market 2025, By The Business Research Company

Hereditary Cancer Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

Hereditary Angioedema Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report

Hereditary Breast And Ovarian Cancer Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hereditary-breast-and-ovarian-cancer-syndrome-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795